Jordan Lukacs, PhD

Dr. Lukacs is a postdoctoral fellow who started in the Oser laboratory in January 2026. His postdoctoral research is focused on utilizing in vivo CRISPR/Cas9 screening approaches to better understand how to restore antigen presentation machinery to promote tumor immunogenicity in SCLC. Jordan is from Fort Erie, Ontario, Canada and received his PhD at Dalhousie University in Halifax where he explored combination immunotherapy approaches with fusogenic oncolytic viruses, immune checkpoint blockade, as well as NKT cell activation in a genetically engineered mouse model of non-small cell lung cancer.